GlassScriptPhysician profile
Karolina S Varnay
NPI 1285807198
$783.13
in general payments reported to CMS, 2019-2025
11 companies · $35.26 in 2025
The $35.26 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.88 · 2020: $96.49 · 2021: $73.49 · 2022: $243 · 2023: $204 · 2024: $99.06 · 2025: $35.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $276.55 | 2019-2024 | Hammertube, Precision Guide Lapidus, Portfolio |
| Stryker Corporation | $166.03 | 2022-2024 | Prostep, Ortholoc 3di |
| Depuy Synthes Sales INC. | $89.01 | 2022 | |
| Bioventus LLC | $87.50 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Organogenesis INC. | $41.12 | 2023 | Puraply |
| Wright Medical Technology, INC. | $31.82 | 2020 | |
| Grt US Holding, INC. | $25.11 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.04 | 2024 | Jublia |
| Nevro Corp. | $19.28 | 2022 | |
| Paratek Pharmaceuticals, INC. | $16.27 | 2023 | Nuzyra |
| Biocomposites INC | $8.40 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karolina Varnay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.